Orbimed Advisors as of Sept. 30, 2021
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 170 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Springworks Therapeutics (SWTX) | 4.3 | $382M | 6.0M | 63.44 | |
Prelude Therapeutics (PRLD) | 3.5 | $314M | 10M | 31.25 | |
Horizon Therapeutics Pub L SHS | 3.2 | $286M | 2.6M | 109.54 | |
Merck & Co (MRK) | 3.1 | $280M | 3.7M | 75.11 | |
Bristol Myers Squibb (BMY) | 3.0 | $267M | 4.5M | 59.17 | |
Boston Scientific Corporation (BSX) | 2.8 | $253M | 5.8M | 43.39 | |
Mirati Therapeutics | 2.7 | $243M | 1.4M | 176.91 | |
Edgewise Therapeutics (EWTX) | 2.6 | $232M | 14M | 16.60 | |
Adagio Therapeutics (IVVD) | 2.5 | $227M | 5.4M | 42.24 | |
Pmv Pharmaceuticals (PMVP) | 2.4 | $218M | 7.3M | 29.80 | |
Natera (NTRA) | 1.9 | $175M | 1.6M | 111.44 | |
Iovance Biotherapeutics (IOVA) | 1.8 | $164M | 6.6M | 24.66 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $159M | 877k | 181.39 | |
Turning Point Therapeutics I | 1.7 | $157M | 2.4M | 66.43 | |
Guardant Health (GH) | 1.7 | $153M | 1.2M | 125.01 | |
Abbvie (ABBV) | 1.7 | $153M | 1.4M | 107.87 | |
UnitedHealth (UNH) | 1.7 | $152M | 390k | 390.74 | |
Ikena Oncology Nonvoting | 1.7 | $150M | 12M | 12.62 | |
Arcutis Biotherapeutics (ARQT) | 1.6 | $145M | 6.1M | 23.89 | |
Intuitive Surgical Com New (ISRG) | 1.5 | $139M | 140k | 994.15 | |
Spdr Ser Tr S&p Biotech (XBI) | 1.5 | $134M | 1.1M | 125.71 | |
Humana (HUM) | 1.4 | $130M | 335k | 389.15 | |
Edwards Lifesciences (EW) | 1.4 | $128M | 1.1M | 113.21 | |
Dex (DXCM) | 1.4 | $125M | 228k | 546.86 | |
Neurocrine Biosciences (NBIX) | 1.3 | $114M | 1.2M | 95.91 | |
Gracell Biotechnologies Sponsored Ads | 1.2 | $109M | 7.9M | 13.87 | |
Zimmer Holdings (ZBH) | 1.1 | $97M | 661k | 146.36 | |
Stryker Corporation (SYK) | 1.0 | $89M | 337k | 263.72 | |
Kinnate Biopharma | 1.0 | $89M | 3.8M | 23.02 | |
Silverback Therapeutics (SPRY) | 1.0 | $87M | 8.7M | 9.98 | |
Repare Therapeutics Ord (RPTX) | 1.0 | $87M | 3.3M | 26.24 | |
ImmunoGen | 0.9 | $85M | 15M | 5.67 | |
Abcellera Biologics (ABCL) | 0.9 | $84M | 4.2M | 20.04 | |
Xtant Med Hldgs Com New (XTNT) | 0.9 | $81M | 73M | 1.11 | |
Sinovac Biotech SHS (SVA) | 0.9 | $78M | 2.8M | 27.61 | |
Anthem (ELV) | 0.9 | $77M | 207k | 372.80 | |
Janux Therapeutics (JANX) | 0.8 | $75M | 3.5M | 21.63 | |
Deciphera Pharmaceuticals | 0.8 | $74M | 2.2M | 33.98 | |
89bio (ETNB) | 0.8 | $73M | 3.7M | 19.59 | |
Progyny (PGNY) | 0.8 | $71M | 1.3M | 56.00 | |
Passage Bio (PASG) | 0.8 | $69M | 7.0M | 9.96 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.8 | $69M | 613k | 111.93 | |
Keros Therapeutics (KROS) | 0.7 | $66M | 1.7M | 39.56 | |
Biogen Idec (BIIB) | 0.7 | $66M | 234k | 282.99 | |
Neuropace (NPCE) | 0.7 | $64M | 4.0M | 15.85 | |
Crinetics Pharmaceuticals In (CRNX) | 0.7 | $63M | 3.0M | 21.05 | |
Thermo Fisher Scientific (TMO) | 0.7 | $63M | 110k | 571.33 | |
Adicet Bio (ACET) | 0.6 | $57M | 7.2M | 7.84 | |
Oak Street Health | 0.6 | $57M | 1.3M | 42.53 | |
Meiragtx Holdings (MGTX) | 0.6 | $54M | 4.1M | 13.18 | |
Oric Pharmaceuticals (ORIC) | 0.5 | $49M | 2.3M | 20.91 | |
Si-bone (SIBN) | 0.5 | $48M | 2.2M | 21.42 | |
Hca Holdings (HCA) | 0.5 | $47M | 194k | 242.72 | |
Erasca (ERAS) | 0.5 | $46M | 2.2M | 21.22 | |
Select Medical Holdings Corporation (SEM) | 0.5 | $46M | 1.3M | 36.17 | |
Seagen | 0.5 | $46M | 268k | 169.80 | |
Tricida | 0.5 | $45M | 9.6M | 4.64 | |
Theravance Biopharma (TBPH) | 0.5 | $44M | 5.9M | 7.40 | |
Alpine Immune Sciences | 0.5 | $44M | 4.1M | 10.67 | |
Mereo Biopharma Group Ads (MREO) | 0.5 | $42M | 17M | 2.42 | |
Tela Bio (TELA) | 0.5 | $41M | 3.0M | 13.66 | |
Cytek Biosciences (CTKB) | 0.5 | $41M | 1.9M | 21.41 | |
Vectivbio Hldg Ord Shs | 0.4 | $40M | 5.1M | 7.73 | |
Terns Pharmaceuticals (TERN) | 0.4 | $40M | 3.8M | 10.42 | |
Logicbio Therapeutics | 0.4 | $39M | 8.5M | 4.58 | |
Decibel Therapeutics | 0.4 | $38M | 4.9M | 7.71 | |
Galapagos Nv Spon Adr (GLPG) | 0.4 | $38M | 724k | 52.61 | |
Applied Therapeutics (APLT) | 0.4 | $38M | 2.3M | 16.60 | |
Ikena Oncology (IKNA) | 0.4 | $37M | 2.9M | 12.62 | |
Vistagen Therapeutics Com New | 0.4 | $35M | 13M | 2.74 | |
Corvus Pharmaceuticals (CRVS) | 0.4 | $34M | 6.9M | 4.84 | |
Burning Rock Biotech Sponsored Ads | 0.4 | $33M | 1.9M | 17.88 | |
Sierra Oncology Com New | 0.4 | $32M | 1.5M | 21.92 | |
Aeglea Biotherapeutics | 0.4 | $32M | 4.0M | 7.95 | |
Scpharmaceuticals (SCPH) | 0.4 | $32M | 4.8M | 6.65 | |
Gh Research Ordinary Shares (GHRS) | 0.4 | $32M | 1.4M | 22.06 | |
Verona Pharma Sponsored Ads (VRNA) | 0.3 | $31M | 5.7M | 5.48 | |
D Fluidigm Corp Del (LAB) | 0.3 | $30M | 4.6M | 6.59 | |
Cybin Ord (CYBN) | 0.3 | $30M | 13M | 2.19 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.3 | $29M | 2.6M | 11.08 | |
Curis Com New | 0.3 | $28M | 3.5M | 7.83 | |
Mersana Therapeutics (MRSN) | 0.3 | $27M | 2.9M | 9.43 | |
Nanostring Technologies (NSTGQ) | 0.3 | $27M | 556k | 48.01 | |
Vaxcyte (PCVX) | 0.3 | $26M | 1.0M | 25.37 | |
Cullinan Oncology (CGEM) | 0.3 | $26M | 1.1M | 22.57 | |
Fusion Pharmaceuticals | 0.3 | $26M | 3.2M | 7.92 | |
Graphite Bio | 0.3 | $24M | 1.4M | 16.39 | |
Gemini Therapeutics | 0.3 | $24M | 5.8M | 4.04 | |
Acutus Medical (AFIB) | 0.3 | $23M | 2.6M | 8.84 | |
Celldex Therapeutics Com New (CLDX) | 0.2 | $22M | 414k | 53.99 | |
Singular Genomics Systems In | 0.2 | $22M | 2.0M | 11.19 | |
Olema Pharmaceuticals (OLMA) | 0.2 | $22M | 808k | 27.56 | |
Cti Biopharma | 0.2 | $22M | 7.5M | 2.95 | |
Tenet Healthcare Corp Com New (THC) | 0.2 | $21M | 312k | 66.44 | |
Harpoon Therapeutics | 0.2 | $21M | 2.6M | 7.90 | |
Gilead Sciences (GILD) | 0.2 | $20M | 288k | 69.85 | |
Jounce Therapeutics | 0.2 | $20M | 2.7M | 7.43 | |
Uniqure Nv SHS (QURE) | 0.2 | $19M | 586k | 32.01 | |
Verrica Pharmaceuticals (VRCA) | 0.2 | $19M | 1.5M | 12.50 | |
Evolent Health Cl A (EVH) | 0.2 | $18M | 595k | 31.00 | |
Synlogic | 0.2 | $18M | 6.0M | 3.05 | |
Nextcure (NXTC) | 0.2 | $18M | 2.7M | 6.74 | |
Chinook Therapeutics | 0.2 | $18M | 1.4M | 12.76 | |
Imara | 0.2 | $18M | 4.4M | 4.08 | |
Humacyte (HUMA) | 0.2 | $17M | 1.5M | 11.61 | |
Nurix Therapeutics (NRIX) | 0.2 | $17M | 579k | 29.96 | |
Flexion Therapeutics | 0.2 | $17M | 2.8M | 6.10 | |
Rxsight (RXST) | 0.2 | $16M | 1.3M | 12.67 | |
Pulmonx Corp (LUNG) | 0.2 | $16M | 435k | 35.98 | |
Bellus Health Com New | 0.2 | $15M | 2.5M | 6.09 | |
Milestone Pharmaceuticals (MIST) | 0.2 | $15M | 2.6M | 5.71 | |
Galecto (GLTO) | 0.2 | $15M | 4.1M | 3.59 | |
Dice Therapeutics | 0.2 | $14M | 440k | 32.75 | |
Graybug Vision Com Shs | 0.2 | $14M | 4.2M | 3.32 | |
Magenta Therapeutics | 0.2 | $14M | 1.9M | 7.28 | |
CVRX (CVRX) | 0.1 | $13M | 800k | 16.54 | |
Vor Biopharma (VOR) | 0.1 | $13M | 833k | 15.68 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $12M | 1.6M | 7.79 | |
Amgen (AMGN) | 0.1 | $12M | 57k | 212.64 | |
Aclaris Therapeutics (ACRS) | 0.1 | $12M | 652k | 18.00 | |
Aerovate Therapeutics (AVTE) | 0.1 | $11M | 536k | 20.98 | |
Catalyst Biosciences Com New | 0.1 | $11M | 2.7M | 4.11 | |
9 Meters Biopharma | 0.1 | $11M | 8.6M | 1.30 | |
Alx Oncology Hldgs (ALXO) | 0.1 | $11M | 150k | 73.86 | |
Kezar Life Sciences (KZR) | 0.1 | $11M | 1.3M | 8.64 | |
Century Therapeutics (IPSC) | 0.1 | $10M | 407k | 25.16 | |
Aadi Bioscience (AADI) | 0.1 | $10M | 346k | 29.37 | |
Oncocyte | 0.1 | $10M | 2.9M | 3.56 | |
Wm Technology (MAPS) | 0.1 | $10M | 700k | 14.50 | |
Novavax Com New (NVAX) | 0.1 | $9.4M | 46k | 207.31 | |
Cytomx Therapeutics (CTMX) | 0.1 | $9.3M | 1.8M | 5.09 | |
Kala Pharmaceuticals | 0.1 | $9.0M | 3.4M | 2.62 | |
Nautilus Biotechnology (NAUT) | 0.1 | $8.9M | 1.5M | 6.14 | |
Chardan Healthcare Acqu- Ord (PHGE) | 0.1 | $8.6M | 2.8M | 3.06 | |
BioMarin Pharmaceutical (BMRN) | 0.1 | $8.6M | 111k | 77.29 | |
Convey Hldg Parent | 0.1 | $8.4M | 1.0M | 8.40 | |
Syros Pharmaceuticals | 0.1 | $8.2M | 1.8M | 4.47 | |
Regeneron Pharmaceuticals (REGN) | 0.1 | $8.2M | 14k | 605.16 | |
I Mab Sponsored Ads (IMAB) | 0.1 | $8.1M | 111k | 72.49 | |
Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.1 | $7.9M | 6.0M | 1.31 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $7.3M | 477k | 15.28 | |
X4 Pharmaceuticals (XFOR) | 0.1 | $7.3M | 1.4M | 5.29 | |
Intellia Therapeutics (NTLA) | 0.1 | $7.1M | 53k | 134.15 | |
Field Trip Health Ord | 0.1 | $7.0M | 1.5M | 4.55 | |
Surface Oncology | 0.1 | $6.9M | 910k | 7.57 | |
Owlet Com Cl A | 0.1 | $6.7M | 1.2M | 5.59 | |
Sarepta Therapeutics (SRPT) | 0.1 | $6.0M | 65k | 92.47 | |
Prometheus Biosciences | 0.1 | $5.9M | 250k | 23.71 | |
Nanobiotix Sa Sponsored Ads (NBTX) | 0.1 | $5.7M | 500k | 11.36 | |
Aptose Biosciences Com New | 0.1 | $5.7M | 2.6M | 2.18 | |
Procept Biorobotics Corp (PRCT) | 0.1 | $5.1M | 135k | 38.15 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.9M | 500k | 9.89 | |
Sight Sciences (SGHT) | 0.1 | $4.5M | 200k | 22.70 | |
Repligen Corporation (RGEN) | 0.0 | $4.3M | 15k | 288.98 | |
Landos Biopharma | 0.0 | $4.1M | 283k | 14.60 | |
Adagene Ads (ADAG) | 0.0 | $3.9M | 275k | 14.36 | |
Cabaletta Bio (CABA) | 0.0 | $3.7M | 303k | 12.16 | |
Syndax Pharmaceuticals (SNDX) | 0.0 | $3.6M | 191k | 19.11 | |
Aslan Pharmaceuticals Ads | 0.0 | $3.5M | 2.0M | 1.78 | |
Inozyme Pharma (INZY) | 0.0 | $3.4M | 294k | 11.59 | |
Talaris Therapeutics | 0.0 | $3.4M | 247k | 13.56 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $3.1M | 450k | 6.92 | |
Inflarx Nv (IFRX) | 0.0 | $2.8M | 1.1M | 2.59 | |
Strongbridge Biopharma Shs Usd | 0.0 | $1.6M | 795k | 2.04 | |
Longboard Pharmaceuticals In (LBPH) | 0.0 | $1.0M | 114k | 8.85 | |
Wm Technology *w Exp 06/16/202 Call Option (MAPSW) | 0.0 | $649k | 150k | 4.32 | |
Phasebio Pharmaceuticals | 0.0 | $551k | 177k | 3.11 | |
Aptinyx | 0.0 | $359k | 153k | 2.34 | |
Astrazeneca Sponsored Adr Call Option (AZN) | 0.0 | $312k | 5.2k | 60.00 | |
Owlet *w Exp 09/14/202 Call Option (OWLTW) | 0.0 | $207k | 221k | 0.94 |